doi: 10.1056/NEJMoa0806470 4 HolmanRRPaulSKBethelMANeilHAMatthewsDR
However, the use of traditional anti-diabetic drugs, in most cases, does not significantly reduce macrovascular morbidity and mortality
The weight loss achieved with GLP-1 medications now approaches what was previously only achievable through surgical intervention, though the most severe cases may still benefit from combined approaches
GLP-1 injections are utilized for medical weight loss by enhancing satiety and slowing digestion, effectively helping patients reduce calorie intake and manage their weight
Injectable glucagon-like peptide-1 agonists, or GLP-1s, began as diabetes medications
Dosing schedules for GLP-1 medications are established through clinical trials that evaluate efficacy, safety, and patient adherence